HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired ability of neutrophils to produce oxygen-derived free radicals in patients with chronic liver disease and hepatocellular carcinoma.

Abstract
To evaluate whether neutrophil bactericidal function, the ability to produce oxygen-derived free radicals, is altered in patients with chronic liver disease, we measured chemiluminescence amplified by a luciferin analog (Cypridina luciferin analog-dependent chemiluminescence) and luminol (luminol-dependent chemiluminescence) in response to N-formyl-Met-Lue-Phe by neutrophils from patients with chronic liver diseases due to C and/or B type hepatitis: chronic active hepatitis, cirrhosis and hepatocellular carcinoma. Both Cypridina luciferin analog-dependent chemiluminescence and luminol-dependent chemiluminescence were significantly decreased in neutrophils from patients with chronic liver disease (hepatocellular carcinoma < cirrhosis < chronic active hepatitis) when they were compared with normal healthy subjects. The reduction of Cypridina luciferin analog-dependent chemiluminescence in chronic active hepatitis and cirrhosis was more sensitive than Cypridina luciferin analog-dependent chemiluminescence; however, in hepatocellular carcinoma, luminol-dependent chemiluminescence was more reduced than luminol-dependent chemiluminescence. Although there were not significant correlations between glutamic pyruvic transaminase and Cypridina luciferin analog-dependent chemiluminescence/luminol-dependent chemiluminescence, there were significant negative correlations between total bilirubin and Cypridina luciferin analog-dependent chemiluminescence/luminol-dependent chemiluminescence. Furthermore, there were significant positive correlations between albumin/prothrombin time and Cypridina luciferin analog-dependent chemiluminescence/luminol-dependent chemiluminescence. These data suggest that an impaired ability to produce oxygen-derived free radicals may contribute to the susceptibility to infection in patients with chronic liver disease.
AuthorsM Uehara, N Sato
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 20 Issue 2 Pg. 326-30 (Aug 1994) ISSN: 0270-9139 [Print] United States
PMID8045492 (Publication Type: Journal Article)
Chemical References
  • Free Radicals
  • Pyrazines
  • Serum Albumin
  • 2-methyl-6-phenyl-3,7-dihydroimidazo(1,2-a)pyrazin-3-one
  • Luminol
  • Alanine Transaminase
  • Bilirubin
  • Oxygen
Topics
  • Alanine Transaminase (blood)
  • Bilirubin (blood)
  • Carcinoma, Hepatocellular (blood, immunology)
  • Chronic Disease
  • Female
  • Free Radicals
  • Hepatitis, Chronic (immunology)
  • Humans
  • Liver Cirrhosis (immunology)
  • Liver Diseases (blood, immunology)
  • Liver Neoplasms (blood, immunology)
  • Luminescent Measurements
  • Luminol
  • Male
  • Middle Aged
  • Neutrophils (immunology, metabolism)
  • Oxygen (metabolism)
  • Prothrombin Time
  • Pyrazines
  • Serum Albumin (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: